Sensei Biotherapeutics, Inc.

SNSE · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$9,994$13,011$17,795$7,159
Short-Term Investments$31,341$52,746$89,321$140,462
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$594$1,493$1,473$921
Total Curr. Assets$41,929$67,250$108,589$148,542
Property Plant & Equip (Net)$3,384$7,038$9,724$4,644
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$48$86$63$39
Total NC Assets$3,432$7,124$9,787$4,683
Other Assets$0$0-$1$0
Total Assets$45,361$74,374$118,375$153,225
Liabilities
Payables$1,248$1,694$4,473$2,456
Short-Term Debt$2,318$2,439$2,131$680
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,882$1,510$2,462$1,753
Total Curr. Liab.$5,448$5,643$9,066$4,889
LT Debt$1,527$3,769$5,902$1,674
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$67$0$149
Total NC Liab.$1,527$3,836$5,902$1,823
Other Liabilities$0$0$0$0
Cap. Leases$1,527$6,208$8,033$2,354
Total Liabilities$6,975$9,479$14,968$6,712
Equity
Pref Stock$0$0$0$0
Common Stock$3$3$3$3
Retained Earnings-$262,052-$231,895-$197,794-$149,206
AOCI-$13-$209-$1,004-$333
Other Equity$300,448$296,996$302,202$296,049
Total Equity$38,386$64,895$103,407$146,513
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$45,361$74,374$118,375$153,225
Net Debt-$6,149-$6,803-$9,762-$4,805